We are actively cooperating with researchers and third-party platforms engaged in COVID-19 research and treatment development. We will continue to provide high-quality products, services, consultation and a high level of responsiveness to support the research and development of new coronaviruses worldwide.
Our Technology
As one of the sirna companies with customers around the world, we are ambitious, grow fast, and are committed to providing the best siRNA drug development services. We have an impeccable track record of helping customers with sirna rna drug design and in vivo delivery.
Products and Services
Oligo can be used for targeted gene therapy. It’s necessary to analyze and purify the Oligo after synthesis to get high purity products for drug discovery or biomedical research.
As an RNAi effector molecule, siRNA regulates the expression of eukaryotic genes at the most important level of genomic function, including chromatin structure, RNA processing/stabilization…
siRNA
The drug delivery system has become an effective tool for transporting drug candidates in vivo. It can not only provide drug stability but also be targeted.
Prevention and treatment of human diseases can be achieved by delivering mRNA encoding disease-specific antigens into the body.
Science Advisor
We collaborate with Shiyue Fang’s group from Michigan Technological University on sensitive DNA/RNA synthesis.
Science Advisor: Prof Shiyue Fang
- Postdoctoral in Nucleic Acid Chemistry, Purdue University (2001-2004)
- Ph.D. in Organic Chemistry from University of Missouri-St. Louis (2001)
- M.S. degree in Organic Chemistry from Chinese Academy of Sciences (1994)
